Ongoing evolution of response assessment in glioma

The complex heterogeneity and therapeutic resistance of malignant glioma may largely account for the poor prognosis of glioma. The incomplete response assessment system of clinical outcomes is an underlying cause for the confounding of true prognostic benefits expected in patients with glioma. The i...

Full description

Bibliographic Details
Main Authors: Li YI, Xu⁃ya WANG, Shu⁃guang CHU, Zhi⁃yong QIN, Xue⁃jun YANG
Format: Article
Language:English
Published: Tianjin Huanhu Hospital 2019-11-01
Series:Chinese Journal of Contemporary Neurology and Neurosurgery
Subjects:
Online Access:http://www.cjcnn.org/index.php/cjcnn/article/view/2044